Español 
Deutsch 
Français 
MSCI World Index (MSC)
NASDAQ Composite (NASDAQ)
FTSE China A50 Index (FGI)
STOXX Europe 600 (SIX)
Nikkei 300 (OSA)
NIFTY 50 (NSE)
DAX Performance Index (XETRA)
FTSE 100 (FGI)
CAC 40 (EURONEXT)
Boutiques, Inc. (9272.T)
Tokyo, JP
Operating from its Tokyo, Japan headquarters since its incorporation in 2006, Boutiques, Inc. engages in three core business activities: organizing trade exhibitions, providing M&A brokerage services, and delivering human resources recruitment support. The company orchestrates specialized negotiation-based expos, like CareTEX, which showcases products and equipment for the nursing care sector. Additionally, it conducts online and hybrid events, such as DXPO, focusing on information technology and digital transformation. In its M&A advisory capacity, Boutiques, Inc. facilitates business acquisitions and divestitures across a diverse range of industries including nursing care, hospitals and clinics, disability welfare, IT, pharmacies, childcare facilities, and construction. Moreover, its human resources division offers career consulting to job applicants, aiding in the placement of both recent university graduates and experienced mid-career professionals, while also maintaining the "Jobtra Academy" online platform as a resource for job hunters.
No mergers or acquisitions recorded for this company.
| Indicator | 1D | 1W | 2W | 3W | 1M |
|---|
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
| 1D | 5D | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| +3.29% | -3.97% | -8.33% | -7.93% | +14.44% | +5.44% | +14.71% | -36.60% | +105.01% | +72.40% | +72.40% |
Revenue flow
Revenue by geography
Revenue by segment
Revenue composition
By product
By geography
Income Statement
Balance Sheet
Cash Flow Statement
Key Metrics
Financial Ratios
Employees
Financial Growth (CAGR)
Market Data
DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.
| Rating | 2024-11 | Change |
|---|---|---|
| Strong Buy | 0 | 0 |
| Buy | 0 | 0 |
| Hold | 0 | 0 |
| Sell | 0 | 0 |
| Strong Sell | 0 | 0 |
-
Revenue growth Specialty Retail: +6.4%+5.8% Q1'26: +4.7% (vs Q1'25)
-
EPS growth Specialty Retail: +20.6%+147.9% ★ Q1'26: +692.5% (vs Q1'25)
-
FCF margin FCF growth · Specialty Retail: +29.3%+26.5% ★ Q1'26: +0.0% (vs Q1'25)
-
EBIT margin Specialty Retail: +5.4%+28.5% ★ Q1'26: +42.3% (vs Q1'25)
-
ROIC Specialty Retail: +6.5%— Q1'26: -215.1% (vs Q1'25)
-
Share dilution Specialty Retail: +0.1%-0.4% ★ Q1'26: -0.3% (vs Q1'25)
-
Debt / EBITDA Net debt/EBITDA · Specialty Retail: 0.14×0.42× ★ Q1'26: 0.21× (vs Q1'25)
* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.
| Metric |
Mar 2018 actual |
Mar 2019 actual |
Mar 2020 actual |
Mar 2021 actual |
Mar 2022 actual |
Mar 2023 actual |
|---|---|---|---|---|---|---|
| Revenue |
1.36B
est.
|
1.61B
est.
|
1.36B
est: 1.55B (-12.4%)
|
1.28B
est: 1.35B (-5.5%)
|
2.09B
est: 1.61B (+29.9%)
|
3.05B
est: 1.87B (+62.7%)
|
| EBITDA |
344.74M
est.
|
408.71M
est.
|
214.95M
est: 393.73M (-45.4%)
|
306.95M
est: 343.21M (-10.6%)
|
589.00M
est: 408.71M (+44.1%)
|
981.67M
est: 475.47M (+106.5%)
|
| EBIT |
315.00M
est.
|
373.46M
est.
|
205.59M
est: 359.77M (-42.9%)
|
295.95M
est: 313.61M (-5.6%)
|
564.49M
est: 373.46M (+51.2%)
|
946.53M
est: 434.46M (+117.9%)
|
| Net Income |
92.16M
est.
|
154.71M
est.
|
130.75M
est: 201.56M (-35.1%)
|
198.60M
est: 147.25M (+34.9%)
|
349.42M
est: 211.60M (+65.1%)
|
621.59M
est: 280.59M (+121.5%)
|
| SGA |
809.38M
est.
|
959.57M
est.
|
793.61M
est: 924.41M (-14.1%)
|
816.17M
est: 805.80M (+1.3%)
|
1.26B
est: 959.57M (+31.3%)
|
1.65B
est: 1.12B (+48.1%)
|
| EPS |
8.95
est.
|
15.03
est.
|
13.26
est: 19.58 (-32.3%)
|
19.89
est: 14.30 (+39.1%)
|
34.71
est: 20.55 (+68.9%)
|
61.93
est: 27.25 (+127.3%)
|
| Date | Rating | Overall | DCF | ROE | ROA | D/E | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
| 2026-05-19 | A- | 4/5 | 4/5 | 5/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-18 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 3/5 | 2/5 | 1/5 |
| 2026-05-15 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-05-14 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-05-13 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-05-12 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-05-11 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-05-08 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-05-07 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-05-01 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-30 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-28 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-27 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-24 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-23 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-22 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-21 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-20 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-17 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 1/5 |
| 2026-04-16 | B+ | 3/5 | 4/5 | 4/5 | 5/5 | 2/5 | 2/5 | 1/5 |
Owner Earnings
Ownership Overview
Ownership breakdown not available.
No beneficial ownership filings recorded.
Institutional Activity (13F)
Institutional history not available.
Top holders not available.
ETF Ownership
This company is not held by any ETF in our universe.
Insider Activity
No insider activity available.
Insider history not available.
No recent insider transactions.
Executive team
Executive compensation
Executive compensation not available.
No CEO compensation history available.
Proxy statements
No proxy statements available for this company yet.
Recent SEC filings
No SEC filings available for this company yet.
Executive team
| Name | Title | Compensation | Gender |
|---|---|---|---|
| Gaku Takeda | MD & Director | — | male |
| Kenji Hayami | MD of Consulting Division & Director | — | male |
| Yuzo Niimura | Chief Executive Officer, President & Chairman | — | male |
No data available for this company.
No Senate trading activity found for this company.
No House trading activity found for this company.
Share your view on this stock and instantly see how the community has voted over the last 6 months.
Community Opinion for 9272.T
Short-term intention
Target Price Distribution
These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.
